Disposición a pagar por vacunas contra el virus papiloma humano en la Región Metropolitana de Santiago de Chile / Willingness to pay for human papillomavirus vaccine in Metropolitan Santiago, Chile
Cerda, Arcadio A; Garcia, Leidy Y; Gaete, Fabián I; Pizarro, Tomas H.
Rev. méd. Chile
; 141(2): 167-172, feb. 2013. tab
Artículo
en Español
| LILACS | ID: lil-675057
Background:
Human papillomavirus (HPV) infection is a risk factor for cervical cancer and can be prevented with the HPV vaccine.Aim:
To explore the willingness of parents to pay for HPV vaccine for their offspring. Material andMethods:
A survey about the willingness to pay for HPV vaccine was answered by 386 individuals of the highest socioeconomic level who had a daughter aged between 12 and 18 years. The survey included information about the risks of HPV infection.Results:
Parents would pay a mean of US$ 758 for the vaccine. Twenty five percent of parents were not willing to pay for it. If the cost of the vaccine would be reduced by 50%, only 4% of parents would not pay for it. The willingness to pay is associated with the price of the vaccine, the income level of respondents and the size of the family.Conclusions:
Most respondents would pay for HPV vaccine for their daughters, despite the relatively high cost.
Biblioteca responsable:
CL1.1
Texto completo
Documentos relacionados